Listed by the USPTO as PERREIRA, MELISSA JEAN
Tech Center 1600 • Art Units: 1618
This examiner grants 52% of resolved cases
PERREIRA, MELISSA JEAN is assigned to Tech Center 1600 and art unit 1618. The profile records 837 resolved cases and an allowance rate of 52.1%. The interview lift is 25.7%, showing a positive recorded association between interviews and allowance outcomes. The median time to allowance is 1375 days.
The listed companies are The Johns Hopkins University, Rakuten Medical Inc., and Hoffmann-La Roche Inc. The leading firms are MORRISON & FOERSTER LLP, MORSE, BARNES-BROWN & PENDLETON, P.C., and FOLEY & LARDNER LLP. Practitioners may combine early interview preparation with focused amendments and continuation planning in view of the recorded pendency.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17542358 | PAPD5 AND PAPD7 INHIBITORS FOR TREATING A HEPATITIS B INFECTION | Non-Final OA | HOFFMANN-LA ROCHE INC. |
| 18062577 | HEMOSTATIC MATERIAL COMPOSITION | Non-Final OA | FUJIFILM CORPORATION |
| 19240908 | METHOD OF TREATING PROSTATE CANCER | Non-Final OA | Novartis AG |
| 16400922 | Pharmaceutical Compositions of Near IR Closed Chain, Sulfo-Cyanine Dyes | Final Rejection | Intuitive Surgical Operations, Inc. |
| 17961299 | RADIOLABELED COMPOUNDS TARGETING THE PROSTATE-SPECIFIC MEMBRANE ANTIGEN | Non-Final OA | THE UNIVERSITY OF BRITISH COLUMBIA |
| 18990863 | IMAGING AND RADIOTHERAPEUTICS AGENTS TARGETING FIBROBLAST-ACTIVATION PROTEIN-ALPHA (FAP-ALPHA) | Final Rejection | The Johns Hopkins University |
| 18052804 | PSMA-TARGETING COMPOUNDS AND USES THEREOF | Non-Final OA | The Johns Hopkins University |
| 18321684 | ACTIVITY-BASED PROBE COMPOUNDS, COMPOSITIONS, AND METHODS OF USE | Non-Final OA | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY |
| 17479395 | FORMULATION OF ACOUSTICALLY ACTIVATABLE PARTICLES HAVING LOW VAPORIZATION ENERGY AND METHODS FOR USING SAME | Non-Final OA | The Regents of the University of Colorado, a body corporate |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy52.1% of resolved applications examined by Melissa Jean Perreira were allowed (837 resolved cases), compared with 33.2% across Art Unit 1618 over the last five years.
This examiner's interview lift is +25.7 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Melissa Jean Perreira took 1,375 days on average from filing to allowance.
Melissa Jean Perreira examines applications in Art Unit 1618 in Tech Center 1600 (Biotechnology & Pharmaceuticals).